Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
108.69
(
3.42%
)
Bitcoin
68,040.01
(
-1.23%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: srsmgja post# 77084

Saturday, 05/02/2009 12:34:29 AM

Saturday, May 02, 2009 12:34:29 AM

Post# of 257269
You just changed the facts of our hypothetical malpractice case in a material way!

If the local drug store is out of Latisse, and I wish to use the EXACT same chemical identity (Lumigan) for cosmesis, there is no basis for malpractice…

The discussion in this thread re off-label use of Lumigan was never predicated on Latisse being out of stock; rather, it was predicated on saving money, pure and simple.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today